مقایسهٔ روشها
روشهای انتخابی خود را کنار هم مرور کنید؛ ردیفهای متفاوت برجسته شدهاند.
| تحلیل بقای عملگرایانه× | مدل رگرسیون کوکس (Cox Proportional Hazards)× | |
|---|---|---|
| حوزه | اپیدمیولوژی | اپیدمیولوژی |
| خانواده | Process / pipeline | Process / pipeline |
| سال پیدایش≠ | Conceptual framework: 1967; widespread application: 1990s–2000s | 1972 |
| پدیدآور≠ | Schwartz & Lellouch (explanatory vs. pragmatic distinction, 1967); extended in survival analysis literature from the 1970s onward | Sir David Roxbee Cox |
| نوع≠ | Observational / experimental hybrid — time-to-event analysis in real-world or pragmatic-trial settings | Semi-parametric regression model |
| منبع بنیادین≠ | Ford, I., & Norrie, J. (2016). Pragmatic Trials. New England Journal of Medicine, 375(5), 454–463. DOI ↗ | Cox, D. R. (1972). Regression models and life-tables. Journal of the Royal Statistical Society: Series B (Methodological), 34(2), 187–202. DOI ↗ |
| نامهای دیگر | real-world survival analysis, pragmatic time-to-event analysis, effectiveness survival analysis, PSA | Cox regression, Cox PH model, proportional hazards model, CPH |
| مرتبط | 5 | 5 |
| خلاصه≠ | Pragmatic survival analysis applies time-to-event statistical methods within pragmatic or real-world settings, estimating how long patients survive, remain event-free, or retain treatment benefit under conditions of routine clinical practice. Unlike explanatory survival analyses conducted under tightly controlled trial conditions, the pragmatic variant embraces the heterogeneity, treatment switching, non-adherence, and competing events that characterise real-world patient populations, prioritising external validity over internal precision. | The Cox proportional hazards model is a semi-parametric regression method that estimates the effect of one or more covariates on the hazard — the instantaneous rate of an event such as death, relapse, or failure — while making no assumption about the shape of the baseline hazard function. Introduced by David Cox in 1972, it is the dominant tool for multivariable survival analysis in clinical and epidemiological research. |
| ScholarGateمجموعهداده ↗ |
|
|